The RUNX1/RUNX1T1 fusion protein also inhibits apoptosis, since the antiapoptotic proteins BCL-2 and BCL-XL are often upregulated in RUNX1/RUNX1T1 AML patients [52,53]. Here, BCL2L1 is linked to acute myeloid leukemia.